Masaharu Mori
Corporate Officer/Principal bei Laboratoires OncoTherapy Science France SARL
Profil
Masaharu Mori is currently a Manager at Laboratoires OncoTherapy Science France SARL since 2014.
Prior to this, he was the President & Representative Director at OncoTherapy Science, Inc. from 2014 to 2017.
He also served as the President & Representative Director at Immunas Pharma, Inc. and as the President at Dojin Iyaku-Kako Co., Ltd.
Aktive Positionen von Masaharu Mori
Unternehmen | Position | Beginn |
---|---|---|
Laboratoires OncoTherapy Science France SARL | Corporate Officer/Principal | 01.10.2014 |
Ehemalige bekannte Positionen von Masaharu Mori
Unternehmen | Position | Ende |
---|---|---|
ONCOTHERAPY SCIENCE, INC. | Präsident | 27.02.2017 |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Präsident | - |
Dojin Iyaku-Kako Co., Ltd.
Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | Präsident | - |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
ONCOTHERAPY SCIENCE, INC. | Health Technology |
Private Unternehmen | 3 |
---|---|
Dojin Iyaku-Kako Co., Ltd.
Dojin Iyaku-Kako Co., Ltd. Pharmaceuticals: MajorHealth Technology Dojin Iyaku-Kaku Co., Ltd. is engaged in the development, production, and distribution of pharmaceutical products and pharmaceutical raw materials. The company was established in 1946 and is based in Tokyo, Japan. | Health Technology |
Laboratoires OncoTherapy Science France SARL | |
Immunas Pharma, Inc.
Immunas Pharma, Inc. Pharmaceuticals: MajorHealth Technology Immunas Pharma, Inc. develops anti-cancer antibody medicines. The company is based in Kawasaki, Japan. Immunas Pharma was acquired by OncoTherapy Science, Inc. on September 30, 2007 for $0.43 million. | Health Technology |